Metabolomics

Microbiome
#Bioinformatics #Gut microbiome #Mergers and acquisitions #Metabolomics #Microbiome

Acquisition will “integrate microbiome and metabolome data”

Microbiome research company Clinical Microbiomics has acquired MS-Omics, a leading provider based in Denmark.   With this acquisition, Clinical Microbiomics hopes to further advance its systems biology platform and help researchers worldwide understand the microbiome and how to impact health and disease.    Anders Grøn, CEO at Clinical Microbiomics, commented: “There is… Read More

#Business & Investment #News

#C elegans #Ion mobility #Mass spectrometry / NMR #Metabolomics

IMS–MS potential for untargeted metabolomics

In this article, Professor Zheng-Zhu (Principal Investigator and Director of Metabolomics Research Center at the Shanghai Institute of Organic Chemistry) and Lucy Woods (Business Unit Manager for Phenomics and Metabolomics at Bruker Daltonics), summarise the most important configurations and options for partnering IMS–MS with liquid chromatography (LC) and show how… Read More

#Editor's Choice #Exclusive Content #News

#Metabolomics #Public health

Collaboration powers metabolomic enriched population health studies 

Metabolon has collaborated with the FinnGen study in Finland to provide metabolomics data for population health studies to improve understanding of human health.  Why collaborate?  FinnGen will incorporate deep metabolomic datasets to better understand how genetic drivers of disease may impact biological function and influence… Read More

#News

#Biology #Data #Drug discovery #Metabolomics #Precision medicine #Research

New metabolomics solution enables understanding of the microbiome 

Metabolon’s first offering from its SmartPanel portfolio aims to provide drug discovery and precision medicine researchers with a novel, dynamic process to explore biologically relevant views of metabolomic data in the context of specific metabolic pathways, biological themes, and disease associations.  “The metabolome offers a window into human… Read More

#Editor's Choice #News #Trending News

#Drug design #Immunology / Virology & Vaccines #Lipidomics #Lipids #Metabolomics

Lipidomics in biomedical research: chance and challenges

Listen to this article on the DDW Podcast: Lipids are essential for numerous functions in the human body. They are not only components of cell membranes, extracellular vesicles and hormones, but also store energy, facilitate metabolism, mediate cell signalling pathways, and much more. Afrisha Anderson, a Product Manager at Merck KGaA,… Read More

#Cancer Research #Editor's Choice #Exclusive Content #News

#Drug discovery #Metabolomics #Precision medicine

Partnership launches clinical metabolomics centre of excellence

Thermo Fisher Scientific and the University of California, Davis (UC Davis) West Coast Metabolomics Center have created The Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations, best practices and standard operating procedures to support the rapid scale-up of large cohort studies and… Read More

#News

#Biopharmaceutical #Drug candidates #Drug development #Drug discovery #Metabolomics

Using the power of plants in drug discovery

Viswa Colluru, PhD, founder and CEO of Enveda Biosciences talks to Lu Rahman about the company’s chemical search engine and its work harnessing the complexity of the natural world to tackle today’s biggest healthcare challenges.  LR: Describe what Enveda does and some of its current work / initiatives. VC: Enveda… Read More

#Exclusive Content #News #Opinion

#Metabolomics #Precision medicine

The advent of metabolic precision medicine

Kirk Pappan, Translational Science Team Lead and Jonathan Kitley, Scientific Content Creator at Owlstone Medical explain why genes are just part of the precision medicine journey. To date, most research around precision medicine has focused on what can be achieved through genetics and genomics. That makes logical sense as a… Read More

#Exclusive Content #News

#Biomarkers #Clinical trials #Drug development #Metabolomics #Metabolon

Life science companies collaborate for drug development

Metabolon and Cleveland Clinic have entered into multi-year collaborative agreement to accelerate research, drug development and precision medicine. Metabolon will leverage its proprietary platform to analyse a range of biologic samples to help discover metabolomic biomarkers that will deepen understanding of Cleveland Clinic’s novel discoveries, improve speed of decision-making and… Read More

#News

#Biotechnology #Coronavirus #Covid-19 #Drug development #Drug discovery #Metabolomics #Metabolon #Narrated podcasts #Pharmaceutical

The potential of metabolomics & COVID-19 Vaccine Development

Today’s episode is titled The potential of metabolomics & COVID-19 Vaccine Development, and covers 2 articles taken from the most recent Fall issue of DDW. These articles are titled: Why metabolomics has the potential to transform diagnosis and treatment. & COVID-19 Vaccine Development: dethroning evil King Coronavirus These articles were firstly… Read More

#Podcasts

#Metabolomics #Pharmaceuticals #Research & development

Boosting pharmaceutical research with microbiome data

Microbiome-based evidence is set to drive understanding of how drugs interact with human ‘host’ environments, helping devise more targeted treatments and create business opportunities, reports Anthony Finbow, CEO of Eagle Genomics. The microbiology of the drug recipient impacts their immune response, allergic responses and more. Increasingly, life sciences R&D is… Read More

#Editor's Choice #Exclusive Content #News #Trends & Analysis

#Biomarkers #Covid-19 #Metabolomics

Study identifies biomarkers that could be used in a quick, inexpensive COVID-19 screening tool

A new study from Lawson Health Research Institute, Western University and University of Alberta suggests that COVID-19 affects the human body’s blood concentration levels of specific metabolites – small molecules broken down in the human body through the process of metabolism. Three specific metabolites identified in this study could act… Read More

#Covid-19 #News

#Clinical specialities #Metabolomics

Metabolomics: the science behind a Tour de France winner

A CU Anschutz research team, experts in athletes’ baseline metabolic profiles and how these physiologies change during competition, are helping guide some of the world’s elite athletes to their best performances, including the recent Tour de France winner. Their understanding of the metabolic underpinnings of top athletes has implications for… Read More

#News

#Metabolomics #Metabolon

Metabolon announces $72 million financing to boost drug development

Metabolon, has announced the close on $72 million in combined debt and equity financing. This round of financing included Perceptive Advisors as a new participant. EW Healthcare Partners and other existing investors also participated in the financing. “We are thrilled by this strong show of support from Perceptive Advisors and… Read More

#News

#DNAGenotek #Metabolomics #Metabolon #Precision medicine

Why metabolomics has the potential to transform diagnosis and treatment

Lu Rahman speaks to key members of Metabolon on the company’s pioneering work in metabolomics including its innovative collaborations with DNAGenotek and the Institute for Systems Biology. “Metabolon has built an unrivalled global biochemical profiling platform capable of providing metabolite data of unsurpassed quality and coverage,” says Brian Keppler, PhD, Director,… Read More

#Exclusive Content #Opinion